O********4
发帖数: 113 | 1 是真偷了有用的东西，还是杀一儆百？
Two GlaxoSmithKline scientists and three others were charged by a federal
grand jury in Philadelphia on Wednesday with conspiracy to steal promising
cancer research secrets from the pharmaceutical giant and market them to
companies in China backed by the Chinese government.
U.S. Attorney Zane David Memeger said Yu Xue, 45, of Wayne; Tao Li, 42, and
Yan Mei, 36, both of Nanjing China; Tian Xue, 45, of Charlotte, N.C.; and
Lucy Xi, 38, of West Lake Village, Calif., were named in the indictment.
If convicted on all charges, each defendant faces possible prison terms,
fines, restitution orders, and other penalties, Memeger said.
Yu Xue was a senior-level manager at GSK's sprawling research lab in Upper
Merion, where she clandestinely downloaded GSK trade secrets and
confidential research data concerning the development of cancer-fighting
monoclonal antibodies, according to the indictment.
MORE COVERAGE
Price-hiking pharma exec Martin Shkreli gets House subpoena
Yu Xue allegedly emailed information "potentially worth hundreds of millions
of dollars or more" relating to a dozen or more products and drug
development processes from her work email account to her personal email, and
then forwarded the information to others in the conspiracy, according to an
affidavit.
The accused, according to the indictment, then formed a Delaware-based
corporation, Renopharma, to eventually market the stolen trade secrets. One
of Renopharma's major investors was the Chinese government, according to
federal investigators. The conspirators allegedly used two China-based
companies to assist in that scheme, Shanghai Renopharma and Nanjing
Renopharma Ltd.
GSK spokeswoman Sarah Spencer said that despite the criminal charges, the
company remained confident that the alleged breach had no discernible impact
on the company's business nor its research and development initiatives.
"We are aware of this issue and have been cooperating fully with the U.S.
authorities," Spencer said. "While we're limited on what we can say about
this ongoing investigation beyond the details in the indictment, we do not
believe the breach has had any material impact on the company's business or
R&D activity," she said.
Yu Xue has hired Peter R. Zeidenberg as her lawyer. He formerly represented
Temple University professor Xiaoxing Xi, an expert in superconductor
research, who was cleared after federal prosecutors accused him of selling
sensitive U.S. defense technology to the Chinese.
"Xue has pled not guilty and we'll be contesting these charges," Zeidenberg
said. "It's one of many cases brought against Chinese Americans in the last
several years, some of which have proved to be vastly overstated. I would
just remind everybody that these are just allegations."
Yu Xue is identified in the indictment as "one of the top protein
biochemists in the world" with a doctoral degree in biological chemistry
from the University of North Carolina.
The world's major pharmaceutical companies have long wrung their hands about
the theft of trade secrets in China and the unwillingness of Chinese
authorities to protect the companies' intellectual property.
The accused often sent emails to one another with news stories about
scientists arrested at other drug companies for stealing trade secrets,
according to court documents.
The indictment alleges that Yu Xue and Lucy Xi, also a GSK scientist, had
received training in the need for trade-secret confidentiality and had been
warned that storing sensitive trade data on personal computers breached
company policy.
Much of the alleged data theft focused on GSK's development of a monoclonal
antibody or protein designed to link up with HER3 human cell receptors that
can under certain conditions spur the development of cancer. The antibody
under development at GSK, and about which the conspirators allegedly stole
trade secrets, was intended to destroy the cell receptors as a means of
halting cancer's spread.
Herceptin, an anticancer drug developed by Genentech that targets a
different set of receptors called HER2, has generated billions of dollars in
revenue for the company.
Pharmaceutical companies assert that the development of one such drug
typically costs shareholders $1 billion or more.
[email protected]
/* */
215-854-5957@cmondics
Read more at http://www.philly.com/philly/business/20160121_U_S__Attorney_indicts_2_GSK_scientists_and_3_others_for_selling_secrets_to_China.html#Lzr5T43wLEt3tym2.99 | F*******n
发帖数: 813 | 2 求中文载要。少于10句。谢谢
and
【在 O********4 的大作中提到】
: 是真偷了有用的东西，还是杀一儆百？
: Two GlaxoSmithKline scientists and three others were charged by a federal
: grand jury in Philadelphia on Wednesday with conspiracy to steal promising
: cancer research secrets from the pharmaceutical giant and market them to
: companies in China backed by the Chinese government.
: U.S. Attorney Zane David Memeger said Yu Xue, 45, of Wayne; Tao Li, 42, and
: Yan Mei, 36, both of Nanjing China; Tian Xue, 45, of Charlotte, N.C.; and
: Lucy Xi, 38, of West Lake Village, Calif., were named in the indictment.
: If convicted on all charges, each defendant faces possible prison terms,
: fines, restitution orders, and other penalties, Memeger said.
|
|
